Prion

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
 +
<StructureSection load='3haf' size='450' side='right' scene='Prion/Cv/3' caption=''>
[[Image:3haf.png|left|200px|thumb|Crystal Structure of human prion [[3haf]]]]
[[Image:3haf.png|left|200px|thumb|Crystal Structure of human prion [[3haf]]]]
-
{{STRUCTURE_3haf| PDB=3haf | SIZE=400| SCENE=Prion/Cv/3 |right|CAPTION=human prion domain swapped dimer complex with Cd+2 (beige) and Cl- (green) ions [[3haf]] }}
+
{{Clear}}
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
'''Prion''' (PrP) is a protein which becomes infectious upon undergoing conformation change to an amyloid form, which is self-propagating and becomes resistant to protease degradation. The fungus ''Podospora anserine'' has a prion-like protein HET-S which undergoes a conformation change to amyloid form which prevents its colony from merging with non-compatible colonies. Yeast prion proteins are Sup35 and Ure2. The images at the left and at the right correspond to one representative prion, ''i.e.'' the crystal structure of human prion ([[3haf]]). For more details see<br />
'''Prion''' (PrP) is a protein which becomes infectious upon undergoing conformation change to an amyloid form, which is self-propagating and becomes resistant to protease degradation. The fungus ''Podospora anserine'' has a prion-like protein HET-S which undergoes a conformation change to amyloid form which prevents its colony from merging with non-compatible colonies. Yeast prion proteins are Sup35 and Ure2. The images at the left and at the right correspond to one representative prion, ''i.e.'' the crystal structure of human prion ([[3haf]]). For more details see<br />
*[[Prion protein]]<br />
*[[Prion protein]]<br />
*[[Human Prion Protein Dimer]].<br />
*[[Human Prion Protein Dimer]].<br />
-
Click here to see <scene name='Prion/Cv/2'>example of prion unfolding</scene> (morph was taken from [http://molmovdb.org/cgi-bin/movie.cgi Gallery of Morphs] of the [http://molmovdb.org Yale Morph Server]).
+
Click here to see <scene name='Prion/Cv/2'>example of prion unfolding</scene> (morph was taken from [http://molmovdb.org/cgi-bin/movie.cgi Gallery of Morphs] of the [http://molmovdb.org Yale Morph Server]).
 +
=== Dominant-negative Effects in Prion Diseases: Insights from Molecular Dynamics Simulations on <scene name='Journal:JBSD:4/Cv/2'>Mouse Prion Protein Chimeras</scene> <ref>doi 10.1080/07391102.2012.712477</ref>===
 +
The key event in prion diseases is the conformational conversion from the cellular form of the [[Prion_protein|prion protein]] (PrP<sup>C</sup>) to its pathogenic scrapie form PrP<sup>Sc</sup> (or prion). PrP<sup>Sc</sup> is the sole causative agent of prion diseases which self-propagates by converting PrP<sup>C</sup> to nascent PrP<sup>Sc</sup>. Mutations in the open reading sequence of the [[Prion_protein|prion protein]] gene can introduce changes in the protein structure and alter PrP<sup>Sc</sup> formation and propagation, possibly by (de)stabilizing the physiological folding of PrP<sup>C</sup> and/or affecting its interactions with some yet unknown cellular factors. Some PrP polymorphisms may even inhibit the wild-type (WT) PrP<sup>C</sup> from being converted to PrP<sup>Sc</sup>, with the so-called “dominant-negative” effect.
 +
Here we use molecular dynamics simulations to investigate the structural determinants of the globular domain in engineered Mouse (Mo) PrP variants, in WT human (Hu) PrP (PDB: [[1hjn]]) and in WT MoPrP (PDB: [[1xyx]]). The Mo PrP variants investigated here contain one or two residues from ''Homo sapiens'' and are denoted “MoPrP chimeras”. <scene name='Journal:JBSD:4/Cv/3'>Some of them are resistant to PrP<sup>Sc</sup> infection</scene> <span style="color:yellow;background-color:black;font-weight:bold;">(colored in yellow)</span> in ''in vivo'' or in ''in vitro'' cell-culture experiments, the <scene name='Journal:JBSD:4/Cv/7'>others are not</scene> <font color='darkmagenta'><b>(in darkmagenta)</b></font>. Our main results are the following: (i) The chimeras resistant to PrP<sup>Sc</sup> infection show <scene name='Journal:JBSD:4/Cv/8'>shorter intramolecular distances</scene> between the &#945;1 helix and N-terminal of &#945;3 helix than HuPrP, MoPrP and the non-resistant chimeras (<scene name='Journal:JBSD:4/Cv/12'>click here to see morph</scene>). This is due to stronger specific interactions between these two regions, mainly the <scene name='Journal:JBSD:4/Cv/9'>Y149-D202 and D202-Y157 (in Hu numbering and hereafter) hydrogen bonds</scene> and the <scene name='Journal:JBSD:4/Cv/10'>R156-E196 salt bridge</scene>. (ii) The &#946;2-&#945;2 <scene name='Journal:JBSD:4/Cv1/2'>loop (residues 167-171)</scene> of PrP<sup>C</sup> is known to differ in its conformation across different species and is suggested to be responsible for the species barrier of PrP<sup>Sc</sup> propagation. Our simulations detect exchanges between different conformations in this loop which can be categorized into two distinct patterns: some chimeras experience a 3<sub>10</sub>-helix/turn pattern like in MoPrP and others show a bend/turn pattern like in HuPrP. In the <span style="color:lime;background-color:black;font-weight:bold;">Mo-like pattern (colored in green)</span>, 3<sub>10</sub>-helix conformation is stabilized by the <scene name='Journal:JBSD:4/Cv1/3'>Q168-P165 and Y169-V166 hydrogen bonds</scene>. In the <font color='darkred'><b>Hu-like pattern (colored in darkred)</b></font>, a <scene name='Journal:JBSD:4/Cv1/4'>D167-S170 hydrogen bond</scene> stabilizes the bend conformation. Interestingly, the dominant-negative effect of MoPrP chimeras over WT MoPrP occurs if the chimera not only resists PrP<sup>Sc</sup> infection but also adopts the Mo-like pattern of exchanges between conformations in the &#946;2-&#945;2 loop. This suggests that the compatible loop conformation allows these dominant-negative chimeras to interfere with the conversion of MoPrP to PrP<sup>Sc</sup>.
 +
The structural features presented here indicate that stronger interactions between &#945;1 helix and N-terminal of &#945;3 helix are related to the resistance to PrP<sup>C</sup> &#8594; PrP<sup>Sc</sup> conversion, while the &#946;2-&#945;2 loop conformation may play an important role in the dominant-negative effect.
 +
</StructureSection>
__NOTOC__
__NOTOC__
-
{{Clear}}
+
 
==3D structures of prion==
==3D structures of prion==

Revision as of 08:43, 13 November 2013

PDB ID 3haf

Drag the structure with the mouse to rotate


3D structures of prion

Updated on 13-November-2013

PrP short polypeptides

3nve – ShPrP residues 138 -143 – Syrian hamster
2kkg - PrP residues 23 -106 – Golden hamster - NMR
3nvf – hPrP residues 138 -143 – human
2ol9 - hPrP residues 170 – 175
3nhc, 3nhd, 3md4, 3md5 - hPrP residues 127 – 132
2iv5 - hPrP residues 173 -195 – NMR
1oei - hPrP residues 61 - 84 – NMR
1oeh - hPrP residues 61 - 68 – NMR
2iv6 - hPrP residues 173 -195 (mutant) – NMR
2iv4 - hPrP residues 180 -195 – NMR
4e1h, 4e1i - hPrP residues 177 -182 + 211-216
3nvg, 3nvh - mPrP residues 138 -143 – mouse
1skh - bPrP residues 1 – 30 - bovine
3fva - ePrP residues 173 -178 – Elk
1s4t - sPrP residues 135 – 155 – sheep – NMR
1m25 - sPrP residues 152 – 156 – NMR
1g04 - sPrP residues 145 – 169 – NMR
2rmv, 2rmw - sPrP residues 142 – 166 (mutant) – NMR

PrP

3o79 – rPrP C-terminal – rabbit
4hls, 4hmm, 4hmr- rPrP C-terminal (mutant)
2fj3 - rPrP C-terminal – NMR
2joh, 2jom - rPrP C-terminal (mutant) – NMR
1xyw – ePrP C terminal - NMR
2ku4 - PrP C-terminal – horse
3fva - ePrP C-terminal – NMR
2kfl - PrP C-terminal – Wallaby – NMR
2k56 - PrP C-terminal – Vole – NMR
2ktm – sPrP residues 167-234 H2H3 domain (mutant) – NMR
1xyu, 1y2s - sPrP C-terminal – NMR
1uw3 - sPrP C-terminal
3haf, 3hak, 3hj5, 1i4m - hPrP C-terminal
1hjm, 1hjn, 2kun – hPrP C-terminal – NMR
1h0l, 1fkc, 2k1d, 1fo7, 1e1s, 1e1g, 1e1j, 1e1p, 1e1u, 1e1w, 1qlx, 1qlz, 1qm0, 1qm1, 1qm2, 1qm3, 1qlz, 1qm0, 1qm1, 2lej- hPrP C-terminal (mutant) - NMR
3heq, 3her, 3hes, 3hjx - hPrP C-terminal (mutant)
2lft, 2lsb - hPrP residues 90 -231 – NMR
2lv1 - hPrP residues 90 -231 (mutant) – NMR
2lsb - hPrP residues 120 -230 + antibody
2ku5, 2ku6, 2kfm, 2kfo, 2k5o, 1y16, 1y15 - mPrP C-terminal (mutant) - NMR
1xyx - mPrP C-terminal - NMR
2l1k, 2l1d, 2l1e, 2l40 - mPrP C terminal (mutant) – NMR
1ag2, 2l1h, 2l39 - mPrP C terminal - NMR
1u3m – PrP C-terminal – chicken – NMR
1u5l - PrP C-terminal – turtle – NMR
1xu0 - PrP C-terminal – frog – NMR
1xyj - PrP C-terminal – cat – NMR
1xyk - PrP C-terminal – dog – NMR
1xyq - PrP C-terminal – pig – NMR
1dwy, 1dx0, 1dx1 - bPrP C-terminal – NMR
1dwz - bPrP C-terminal (mutant) - NMR
1b10 - ShPrP C-terminal – NMR
2lh8 - ShPrP C-terminal + thiamine – NMR

Yeast prions

2onx, 2olx – Sup35 residues 8 - 11 – yeast
2omm, 1yjo, 1yjp – Sup35 residues 7 – 13
1jzr, 1k0a, 1k0b, 1k0c, 1k0d – Ure2p + glutathione derivartive
1g6w, 1g6y – Ure2p globular domain
1hqo – Ure2p nitrogen regulation fragment

PrP+antibody

2w9e, 4h88 - hPrP C-terminal + anti-PrP antibody
2hh0 - bPrP peptide epitope + anti-PrP antibody
1cu4 - ShPrP peptide epitope + anti-PrP antibody
1tpx, 1tqb, 1tqc - sPrP C-terminal + anti-PrP antibody

HET-S from Podospora anserine

2kj3, 2rnm – HET-S C-terminal – NMR
2wvn, 2wvo - HET-S N-terminal
2wvq - HET-S N-terminal (mutant)

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Joel L. Sussman

Personal tools